News Release

Study finds similar long-term outcomes for mechanically-ventilated COVID-19 patients

Treated with and without ECMO

Peer-Reviewed Publication

American Association for Thoracic Surgery

Boston, MA (April 30, 2021) - A new study, presented today at the AATS 101st Annual Meeting, found that severely ill COVID-19 patients treated with ECMO did not suffer worse long-term outcomes than other mechanically-ventilated patients. The multidisciplinary team included cardio thoracic surgeons, critical care doctors, medical staff at long-term care facilities, physical therapists and other specialists, and followed patients at five academic centers: University of Colorado; University of Virginia; University of Kentucky; Johns Hopkins University; and Vanderbilt University.

Survivors of critical illness are at high risk for long-term physical, psychological, and cognitive deficits. Extracorporeal membrane oxygenation (ECMO) shows promising survival benefit for select patients with COVID-19. However, its impact on long-term recovery was unknown. The study measured physical, psychological, and cognitive deficits in in 46 patients who were canulated for ECMO compared to a control group of 262 mechanically ventilated patients who did not receive ECMO.

The multi-disciplinary team conducted a retrospective analysis of mechanically ventilated patients with COVID-19 admitted between March and May 2020. Data were available for all mechanically ventilated patients from three sites, while all five sites provided ECMO patient data. Survivors had access to a multi-disciplinary post-intensive care unit recovery clinic for long-term care. Physical, psychological, and cognitive deficits were measured using validated instruments during follow up. Patient characteristics and long-term outcomes were compared based on ECMO status.

The study found no significant difference in survival at discharge (69.6 percent ECMO vs. 69.9 percent non-ECMO.) Of the 215 survivors across both groups, 93.9 percent were residing at home, 16.1 percent had returned to work or usual activity and 26.2 percent were still using supplemental oxygen; these rates did not differ significantly based on ECMO status. Rates of physical, psychological and cognitive deficits did not differ significantly.

"The initial guidance for ECMO in COVID was helpful and saved a lot of lives, and not to their detriment, which is very encouraging," explained Dr. Jessica Rove, Assistant Professor, Cardiothoracic Surgery at University of Colorado Anschutz Medical Campus, and Section Chief, Cardiac Surgery, Rocky Mountain Regional VA Medical Center. "This multidisciplinary collaboration is committed to examining long-term outcomes beyond survival, and early results look promising. This may help to further refine who should receive ECMO and may increase the rate of positive outcomes."

Further research will continue to follow patients and measure outcomes over the longer term. Dr. Lauren Taylor, fellow at University of Colorado Anschutz Medical Campus explained, "It is exciting that we now have the long term outcomes of these patients and that they are so promising. Further study of these patients over the long term can help to further refine who we are canulating for ECMO, leading to better outcomes for all."


Notes for Editors:

"Long-term Recovery of COVID-19 Survivors is Not Negatively Impacted by ECMO: A Multicenter Study from the ORACLE Group," Lauren J Taylor, Chintan Ramani, Shoaib Fakhri, Kirby P Mayer, Eric W Etchill, Matthew F Mart, Sarah E Jolley, Alexandra Kadl, Skyler Peterson, Ashley A Montgomery-Yates, Ann M Parker, Carla Sevin, Kathryn Colborn, Nicholas Teman, Jordan Hoffman, Kyle Enfield, Karsten Bartels, Bo Soo Kim, Sung-Min Cho, Joseph Hippensteel, Glenn J.R. Whitman, Joseph B Zwischenberger, Jessica Y Rove, University of Colorado, Aurora, CO University of Virginia, Charlottesville, VA; University of Kentucky, Louisville, KY; Johns Hopkins University, Baltimore, MD; Vanderbilt University, Nashville, TN.

Presented by Lauren J. Taylor, April 30, 2021 at the AATS 101st Annual Meeting.


The American Association for Thoracic Surgery (AATS) is an international organization that encourages, promotes, and stimulates the scientific investigation of cardiothoracic surgery. Founded in 1917 by a respected group of the earliest pioneers in the field, its original mission was to "foster the evolution of an interest in surgery of the Thorax." Today, the AATS is the premiere association for cardiothoracic surgeons in the world and works to continually enhance the ability of cardiothoracic surgeons to provide the highest quality of patient care. Its more than 1,500 members have a proven record of distinction within the specialty and have made significant contributions to the care and treatment of cardiothoracic disease. Visit to learn more.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.